TikTok Content Creators Fueling Parallel Trade for Unapproved Slimming Medication

An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are encouraged to contact these accounts privately for source information, while also obtaining promotional offers.

Thriving Trade on Social Networks

Separately, a robust market exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Professionals Express Worries

However, physicians and pharmacists have cautions that the sale of what is still an unlicensed medication in the UK is worrisome and could lead to individuals injecting substances of unknown origin.

Some professionals said the demand for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for human use under the British medical regulations.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate pharmaceutical, advertising, and customer regulations, risking penalties, legal action or imprisonment.

Service Reaction and Content Elimination

Based on the social media company, the platform has removed problematic material and prohibited associated hashtags and search suggestions. The company stated it was committed to maintaining the service secure and investing in strengthening compliance measures.

Online Marketplace Operations

Research also discovered groups with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with numerous of users, populated with photos of slimming results, positive reviews and step-by-step guides for preparing or injecting at home.

Within moments of joining one group, a vendor shared contact information, where the majority of purchases take place. The seller provided an instruction manual and promised shipping within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about body mass, health issues or previous experience.

Item Details and Pricing

Inside these groups, posts show black plastic parcels with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When asked how long a injector should last, sellers give contradictory responses varying between a several days to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service stated it regularly monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering materials they can’t verify. Even if the science behind retatrutide is sound, these online versions may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her staff has previously seen patients injured by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject users to potentially significant health risks”.